Skip to content
PubMed This is a summary of 5 peer-reviewed journal articles Updated
Pediatric Cardiology

What is the Life Expectancy for 22q11.2 Deletion Syndrome?

At a Glance

Thanks to modern medical advances, the vast majority of children diagnosed with 22q11.2 deletion syndrome live well into adulthood. Long-term life expectancy is heavily dependent on heart health, specifically the severity of any congenital heart defects present at birth.

For parents receiving a new diagnosis of 22q11.2 deletion syndrome for their child, questions about life expectancy are often the most immediate and terrifying. The most important thing to know is that because of modern medical advances, the vast majority of children with this diagnosis today will live well into adulthood [1]. While the overall life expectancy for individuals with 22q11.2 deletion syndrome is slightly lower than the general population, many live into their 50s, 60s, and beyond [1].

How long a child with this syndrome will live is highly dependent on the severity of the physical challenges they are born with—most notably, congenital heart defects.

The Early Years: Heart, Immune, and Calcium Health

In early childhood, the greatest risks to life expectancy come from severe structural heart defects, profound immune system issues, or unmanaged calcium levels [1][2][3].

  • Congenital Heart Defects: Heart defects are very common in this syndrome, and their severity varies widely. Complex conditions like Tetralogy of Fallot (a combination of four heart defects that affect blood flow) require early surgical intervention [4]. Historically, these heart issues caused a higher rate of infant loss, but incredible advancements in pediatric heart surgery mean that most babies born with these defects now survive and thrive [1].
  • Immune System Vulnerability: Many children with the syndrome have a weakened immune system, which can lead to frequent respiratory infections [2]. While these recurrent infections are a major source of illness and hospital visits in early life, they are rarely fatal [2]. A very small percentage of infants are born with severe immunodeficiency, which requires immediate, specialized treatment.
  • Hypocalcemia (dangerously low blood calcium): The syndrome can cause underactive parathyroid glands, leading to low calcium levels [3]. If unmanaged, severe hypocalcemia can cause seizures and potentially fatal heart arrhythmias. Lifelong monitoring of calcium levels is a critical part of a child’s care plan [3].

Overall, studies show that childhood mortality affects about 7% of those diagnosed, almost entirely due to complex, early-life medical challenges [5].

Looking Ahead: Adulthood and Lifelong Outlook

As children with 22q11.2 deletion syndrome grow into adults, their long-term survival remains closely tied to their heart health [1].

When reading survival statistics, it is crucial to remember that current adult data is based on individuals who were born decades ago—long before today’s advanced pediatric cardiac surgeries existed. A child born today with these heart defects has a much more optimistic long-term outlook.

Research looking at adults with the syndrome highlights the impact of the initial heart defect:

  • For individuals born without major congenital heart disease, the probability of surviving to age 50 is approximately 85% [1].
  • For individuals born with major congenital heart disease, the probability of surviving to age 50 is approximately 63% [1].

While the median age of death in one large historical study of adults was around 46 years, the range of survival extended into the late 60s, and these numbers are expected to improve significantly for the current generation [1].

Important Long-Term Health Monitoring

Because 22q11.2 deletion syndrome is a lifelong condition, continuous monitoring is critical to managing complications that can arise later in life.

  • Sudden Cardiac Events: Cardiovascular issues are the leading cause of early mortality in adulthood, responsible for roughly 71% of adult deaths in individuals with the syndrome [1]. Sudden cardiac death (an unexpected loss of heart function) is a specific, elevated risk [1]. This risk is notably higher for adults who were born with Tetralogy of Fallot, making lifelong, specialized cardiology care non-negotiable [4].
  • Other Conditions to Monitor: As your child grows, their care team will actively monitor for other conditions associated with the syndrome. This includes managing endocrine issues, immune health, and psychiatric health (such as schizophrenia, which is more common in this syndrome) [3]. While heart health is the leading driver of life expectancy, comprehensive care for mental and physical health is critical for overall well-being, longevity, and the ability to self-care in adulthood [3].

While survival statistics can be difficult to read, they underscore one vital point: proactive, lifelong care from a multidisciplinary team—including a specialized pediatric cardiologist, endocrinologist, and immunologist—is the absolute best way to protect your child’s future.

Common questions in this guide

How long can someone live with 22q11.2 deletion syndrome?
With modern medical advances, the vast majority of children with this diagnosis will live well into adulthood. While overall life expectancy is slightly lower than the general population, many individuals live into their 50s, 60s, and beyond.
What is the main factor that affects life expectancy in 22q11.2 deletion syndrome?
Long-term survival is highly dependent on the presence and severity of congenital heart defects. Adults born without major heart disease have a significantly higher probability of living longer compared to those born with complex heart issues like Tetralogy of Fallot.
Why is calcium monitoring important for children with 22q11.2 deletion syndrome?
This syndrome can cause underactive parathyroid glands, leading to dangerously low blood calcium levels called hypocalcemia. If left untreated, severe hypocalcemia can trigger seizures and potentially fatal heart arrhythmias, making lifelong monitoring essential.
What are the long-term health risks for adults with this syndrome?
Cardiovascular issues are the leading cause of early mortality in adulthood for individuals with this condition. Sudden cardiac death is a specific, elevated risk, especially for adults who were born with structural heart defects, requiring continuous specialized cardiology care.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific congenital heart defects, if any, does my child have, and how do they impact their long-term life expectancy?
  2. 2.How frequently will my child's calcium and parathyroid levels be tested, and what signs of low calcium should I watch for at home?
  3. 3.What is our specific protocol for fevers or potential infections given my child's current immune system status?
  4. 4.What signs of heart trouble or cardiac events should I be most vigilant about right now?
  5. 5.Who will be the primary doctor coordinating the communication between my child's cardiologist, immunologist, and endocrinologist?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (5)
  1. 1

    All-cause mortality and survival in adults with 22q11.2 deletion syndrome.

    Van L, Heung T, Graffi J, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(10)):2328-2335 doi:10.1038/s41436-019-0509-y.

    PMID: 30948858
  2. 2

    Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).

    Kuo CY, Signer R, Saitta SC

    Current allergy and asthma reports 2018; (18(12)):75 doi:10.1007/s11882-018-0823-5.

    PMID: 30377837
  3. 3

    22q11.2 deletion syndrome.

    McDonald-McGinn DM, Sullivan KE, Marino B, et al.

    Nature reviews. Disease primers 2015; (1()):15071 doi:10.1038/nrdp.2015.71.

    PMID: 27189754
  4. 4

    Impact of a 22q11.2 Microdeletion on Adult All-Cause Mortality in Tetralogy of Fallot Patients.

    van Mil S, Heung T, Malecki S, et al.

    The Canadian journal of cardiology 2020; (36(7)):1091-1097 doi:10.1016/j.cjca.2020.04.019.

    PMID: 32348848
  5. 5

    Childhood manifestations of 22q11.2 deletion syndrome: A Finnish nationwide register-based cohort study.

    Wahrmann S, Kainulainen L, Kytö V, Lempainen J

    Acta paediatrica (Oslo, Norway : 1992) 2023; (112(6)):1312-1318 doi:10.1111/apa.16737.

    PMID: 36867048

This page provides general information about life expectancy and health risks associated with 22q11.2 deletion syndrome. It is for informational purposes only and does not replace professional medical advice from your child's multidisciplinary care team.

Get notified when new evidence is published on 22q11.2 deletion syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.